全球獸醫診斷市場規模、佔有率、成長分析、按產品、按動物、按技術 - 產業預測 2023-2030

2022年全球獸醫診斷市場規模將為73億美元，從2023年的81億美元成長到2031年的190億美元，年複合成長率預計將成長11.2%。

近年來，由於動物疾病的流行以及對準確、及時的診斷工具的需求不斷增加，全球獸醫診斷市場經歷了顯著成長。特別是在新興國家，寵物主人數量迅速增加，為獸醫診斷市場的擴張做出了巨大貢獻。此外，人們對獸醫領域的預防性保健越來越感興趣，對早期發現疾病的診斷測試的需求也在增加。伴同性動物醫療保健的顯著成長是寵物飼主越來越願意投資診斷服務以確保其動物的健康。從地區來看，北美和歐洲是獸醫診斷的重要市場，受益於較高的寵物醫療保健意識和完善的獸醫基礎設施。然而，亞太和拉丁美洲的新興經濟體提供了充滿希望的成長機會。這些地區可支配收入的增加和對動物健康意識的提高正在推動獸醫診斷市場的成長。因此，該行業的公司越來越注重擴大在亞太和拉丁美洲的業務，以利用這些快速成長的市場。總體而言，在寵物飼養、預防性醫療保健和擴大地理覆蓋範圍等不斷變化的趨勢的推動下，全球獸醫診斷市場預計將繼續其成長軌跡。

目錄

執行摘要

• 市場概況
• 命運之輪

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 監管形勢
• 波特的分析
• 對未來中斷的特殊考慮

全球獸醫診斷市場：按產品

• 市場概況
• 免疫診斷測試
• 分子診斷測試
• 臨床化學
• 血液分析儀
• 診斷影像

全球獸醫診斷市場：依動物分類

• 市場概況
• 家畜
• 伴同性動物

全球獸醫診斷市場：依技術分類

• 市場概況
• PCR（聚合酵素鏈鎖反應）
• ELISA（酵素結合免疫吸附檢測法）
• 微陣列
• 免疫檢測
• 影像診斷技術（X光）
• MRI
• 超音波
• 其他

按地區分類的全球獸醫診斷市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭形勢

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• IDEXX Laboratories, Inc.
• Zoetis, Inc.
• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Virbac Corporation
• Heska Corporation
• Abaxis, Inc.
• NEOGEN Corporation
• Randox Laboratories Ltd.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
• Danaher Corporation
• Johnson & Johnson
• Pfizer
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health

Global Veterinary Diagnostics Market size was valued at USD 7.3 billion in 2022 and is poised to grow from USD 8.1 billion in 2023 to USD 19.0 billion by 2031, growing at a CAGR of 11.2% during the forecast period (2024-2031).

The global Veterinary Diagnostics market has observed a substantial growth recently, driven by the increasing prevalence of animal diseases and the consequent demand for accurate and timely diagnostic tools. Developed countries, in particular, have seen a surge in pet ownership, contributing significantly to the expansion of the veterinary diagnostics market. Furthermore, there is a growing attention on preventive healthcare in the veterinary field, leading to a rising demand for diagnostic tests aimed at early disease detection. A notable surge in companion animal healthcare is the growing willingness of pet owners to invest in diagnostic services to ensure the well-being of their animals. Geographically, North America and Europe have been prominent markets for veterinary diagnostics, benefiting from a high level of awareness about pet healthcare and well-established veterinary infrastructure. However, emerging economies in Asia-Pacific and Latin America are now presenting promising growth opportunities. Rising disposable incomes and increasing awareness of animal health in these regions are driving the growth of the veterinary diagnostics market. As a result, companies operating in this sector are increasingly focusing on expanding their presence in Asia-Pacific and Latin America to capitalize on these burgeoning markets. Overall, the global veterinary diagnostics market is expected to continue its growth trajectory, propelled by evolving trends in pet ownership, preventive healthcare, and expanding geographical reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Diagnostics Market Segmental Analysis

The global veterinary diagnostics market is segmented on the basis of product, animal, technology, and region. By product type, the market is segmented into immunodiagnostic tests, molecular diagnostic tests, clinical chemistry, hematology analyzers, and diagnostic imaging. By animal type, the market is segmented into livestock, companion animals. By technology, the market is segmented into, PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), microarrays, immunoassay, diagnostic imaging technologies (X-ray, MRI, Ultrasound), and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Global Veterinary Diagnostics Market

The increase in widespread presence of animal diseases emphasizes the need for precise and timely diagnostic tools to ensure prompt treatment and effective disease management. Furthermore, the rise in pet ownership, mainly in developed regions, is a significant driver of market growth because pet owners are increasingly seeking advanced healthcare solutions for their animal companions. Technological advancements in diagnostic tools, including molecular diagnostic tests and advanced imaging techniques, are playing an important role in maintaining the accuracy and efficiency of veterinary diagnostics. These innovations contribute to improved disease detection and treatment outcomes, thus benefiting both animals and their owners.

Restraints in the Global Veterinary Diagnostics Market

The main problem for the veterinary diagnostics market is the high cost of advanced methods and equipment. Buying and running these tools is expensive, especially for clinics and labs in places with little money. Also, there's a challenge because rules about these tools are different in each country. These different rules can make it hard to bring new diagnostic technologies into some places.

Market Trends of the Global Veterinary Diagnostics Market

There's a trend in veterinary diagnostics where high-tech stuff like artificial intelligence and machine learning are getting used more. These technologies help make diagnosing diseases in animals faster and more accurate. Another trend is that vets are using point-of-care diagnostics, where they can do tests right where the animal is being treated. This makes it faster to make decisions and start treatment. Also, telemedicine in veterinary care is becoming more common, where vets can do consultations remotely using digital platforms and share diagnostic information online.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Veterinary Diagnostics Market by Product

• Market Overview
• Immunodiagnostic Tests
• Molecular Diagnostic Tests
• Clinical Chemistry
• Hematology Analyzers
• Diagnostic Imaging

Global Veterinary Diagnostics Market by Animal

• Market Overview
• Livestock
• Companion Animals

Global Veterinary Diagnostics Market by Technology

• Market Overview
• PCR (Polymerase Chain Reaction)
• ELISA (Enzyme-Linked Immunosorbent Assay)
• Microarrays
• Immunoassay
• Diagnostic Imaging Technologies (X-ray
• MRI
• Ultrasound)
• and Others

Global Veterinary Diagnostics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abaxis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments